Cite
The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders
MLA
Masahiro Kizaki, et al. “The Clinical Impact of Absolute Lymphocyte Count in Peripheral Blood among Patients with Methotrexate - Associated Lymphoproliferative Disorders.” Journal of Clinical and Experimental Hematopathology : JCEH, vol. 60, no. 2, May 2020, pp. 41–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7862d90f912932d65d833cfbc4a92548&authtype=sso&custid=ns315887.
APA
Masahiro Kizaki, Shuju Momose, Michihide Tokuhira, Morihiro Higashi, Reiko Nakaseko, Junichi Watanabe, Yasuyuki Takahashi, Jun-ichi Tamaru, Yuta Kimura, Yuka Tanaka, Koichi Amano, Takayuki Tabayashi, Morihiko Sagawa, Tatsuki Tomikawa, & Tomoe Anan. (2020). The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders. Journal of Clinical and Experimental Hematopathology : JCEH, 60(2), 41–50.
Chicago
Masahiro Kizaki, Shuju Momose, Michihide Tokuhira, Morihiro Higashi, Reiko Nakaseko, Junichi Watanabe, Yasuyuki Takahashi, et al. 2020. “The Clinical Impact of Absolute Lymphocyte Count in Peripheral Blood among Patients with Methotrexate - Associated Lymphoproliferative Disorders.” Journal of Clinical and Experimental Hematopathology : JCEH 60 (2): 41–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7862d90f912932d65d833cfbc4a92548&authtype=sso&custid=ns315887.